Skip to main content

Pharma firm plans to import Covid-19 treatment drug from Bangladesh

KARACHI: A local pharmaceutical company plans to import a generic version of remdesivir — a broad spectrum antiviral medication that has shown to reduce recovery time in Covid-19 patients — from a Bangladesh-based manufacturer.

The drug has been granted emergency use authorisation by the US Food and Drug Administration (FDA) and authorities in Japan and the UK to treat hospitalised patients with severe manifestations of coronavirus.

According to a statement released by Searle Company Limited on Friday, the firm has entered into an exclusive licensing and marketing agreement with Beximco Pharmaceuticals, Bangladesh.

“It’s the first company in the world to introduce the generic variant of the drug. Our partnership will provide an immediate supply of the finished product at an affordable price and will help healthcare providers of Pakistan to treat their hospitalised Covid-19 patients without any delay,” said Mohammad Sajid, business development director at Searle.

Company asks authorities for urgent regulatory approval

The company decided not to make any commercial profit from the import (till the time the pandemic is over) and also to donate it to the government and Covid-19-designated hospitals, he added.

Asked about drug price in Bangladesh and its dosage, Mr Sajid said it cost around $70 per vial and six to a dozen vials were administered to a patient depending upon disease’s severity.

“Remdesivir is a direct-acting viral drug that inhibits viral RNA (Ribonucleic acid) synthesis. It is administrated intravenously and is authorized for the treatment of hospitalized patients with severe Covid-19 infection.”

Searle, he said, was actively taking the matter to the relevant authorities of Pakistan for necessary regulatory approval and was confident that in the existing pandemic, the relevant authorities would consider the matter on an urgent basis to support the product availability.

“Meanwhile, the drug would be imported under the patient access programme, which allows import when hospitals make a demand.”

Bangladesh, according to experts, has made remarkable progress in the pharmaceutical sector in recent years.

Some Bangladesh-based pharmaceutical companies, they said, were approved by the FDA and exported their products to the US. The global trade rules allow nations defined by the United Nations as least-developed countries (LDCs) to manufacturer patented drugs to make them more affordable in their markets. Bangladesh is one of 47 countries that fall in this category while Pakistan is not.

Remdesivir is currently undergoing clinical trials around the world, including in the UK. Early data suggests it can cut recovery time by about four days, but so far there has been no evidence that it will save more lives.

Earlier this month, Ferozsons Laboratories Limited, a subsidiary of BF Biosciences Ltd, said it would make the drug in Pakistan after signing a non-exclusive licensing pact with the US-based Gilead, which manufactured the drug, to make and sell the drug to 127 nations. However, the pharmaceutical company had announced that its production could take weeks.

Published in Dawn, May 30th, 2020



from The Dawn News - Home https://ift.tt/2AiH1wC
via IFTTT
Labels:

Comments

Post a Comment

Popular posts from this blog

Trump says he urged team to ‘slow’ COVID-19 testing

US President Donald Trump said Saturday he was encouraging health officials in his administration to slow down coronavirus testing, arguing that increased tests lead to more cases being discovered. The president has claimed falsely on several occasions that surges of COVID-19 in several states can be explained by greater numbers of diagnostic tests. At his first rally since the outbreak forced nationwide shutdowns in March, Trump told the crowd in Tulsa, Oklahoma that testing was a “double-edged sword.” The United States — which has more deaths and cases than any other country — has carried out more than 25 million coronavirus tests, placing it outside the top 20 countries in the world, per capita. “Here is the bad part: When you do testing to that extent, you are going to find more people, you will find more cases,” Trump argued. “So I said to my people ‘slow the testing down.’ They test and they test.” It was not clear from Trump’s tone if he was playing to the crowd, who ...
Post a Comment
Read more

IT ministry forms panel to review social media rules

ISLAMABAD: While uproar against the new rules to regulate social media continues from various segments of society, including parliamentarians, the Pakistan Federal Union of Journalists (PFUJ) and civil society, the information technology ministry on Friday formed a committee to review the rules. The federal cabinet approved the rules on Feb 11, but later after opposition from various quarters, including companies that manage different social media platforms, the prime minister announced that a fresh consultation process would be launched over the Citizens Protection (Against Online Harm) Rules 2020. The committee formed by the IT ministry is headed by Pakistan Telecommunication Authority Chairman Amir Azeem Bajwa while its members are Eazaz Aslam Dar, additional secretary of IT; Tania Aidrus, member of the Strategic Reforms Imple­mentation Unit, Prime Minister Office; and Dr Arslan Khalid, focal person on digital media at the PM Office. Federal Minister for Human Rights Dr Shireen Ma...
Post a Comment
Read more

IS confirms Baghdadi’s death, vows revenge

Abu Bakr al-Baghdadi.—AP BEIRUT: The Islamic State militant group confirmed the death of its leader Abu Bakr al-Baghdadi in a statement on Thursday and named his replacement as Abu Ibrahim al-Hashimi al-Quraishi. “We mourn you ... commander of the faithful,” said Abu Hamza al-Quraishi — presented as the group’s new spokesman — in an audio statement. Baghdadi, who led IS since 2014 and was the world’s most wanted man, was killed in a US special forces raid in Syria’s province of Idlib on Sunday. The group also confirmed the killing in another raid the following day of the group’s previous spokesman Abu Hassan al-Muhajir. The statement said the group’s legislative and consultative body convened after the 48-year-old Iraqi-born jihadist chief’s death. “The Islamic State shura council convened immediately after confirming the martyrdom of Sheikh Abu Bakr al-Baghdadi, and the elders of the holy warriors agreed” on a replacement, said the seven-minute message. Little is known abou...
Post a Comment
Read more